The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was JOD 1.96 million compared to JOD 2.65 million a year ago. Net loss was JOD 2.43 million compared to JOD 0.702931 million a year ago. Basic loss per share from continuing operations was JOD 0.035 compared to JOD 0.01 a year ago.
For the nine months, sales was JOD 8.86 million compared to JOD 9.87 million a year ago. Net loss was JOD 4.18 million compared to JOD 1.93 million a year ago. Basic loss per share from continuing operations was JOD 0.06 compared to JOD 0.028 a year ago.